Market by Procedure, Type of Infection, Industry Vertical, Product, and Country | Forecast 2021-2028
As per Triton’s
research report, the Middle East and Africa’s market for surgical site
infection control is anticipated to surge with a CAGR of 6.46% in terms of revenue
over the forecasting phase from 2021 to 2028.
Report scope can be customized per your requirements. Request For Customization
The countries evaluated
in this market include:
• Israel
• The United Arab Emirates
• Saudi Arabia
• South Africa
• Turkey
• Rest of MEA
Every type of surgical
procedure is likely to result in an infection. Preventing the occurrence of
these infections is a better option as compared to treating them, as the former
is a simple and inexpensive process. In the United Arab Emirates, an infection
control manual consisting of policies and guidelines for the country’s
healthcare institutions was introduced by the Ministry of Health, as part of
its efforts to tackle this growing challenge. Such initiatives are expected to
aid the development of the UAE’s market for surgical site infection control in
the upcoming period.
A high number of
patients undergoing abdominal surgery report acquiring surgical site
infections. According to a recently published research article, a prospective
cohort study was conducted at Israel’s Western Galilee Medical Center, Nahariya.
It studied the medical data of patients who had undergone abdominal surgeries
between the years 2005 and 2007. It was found that 22.2% of the total 302
patients, whose data was studied, reported having had these surgical site
infections. In addition, according to a report from the State Comptroller’s
Office, approximately 4000 to 6000 patients in the country end up losing their
lives due to complications arising out of hospital-acquired infections each
year. The high rate of incidence of SSIs shows that there is a dire need for
surgical site infection control practices in Israel. This need is expected to
fuel the demand for the SSI control market growth in the country in the years
to come.
Stryker Corporation is
a med-tech company established in 1941. The company’s major product portfolio comprises
surgical equipment, surgical navigation systems, and orthopedic implants, among
others. Stryker has a notable presence in the Middle East and Africa, and operates
its R&D facilities in some of the countries in the region.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. MIDDLE
EAST AND AFRICA SURGICAL SITE INFECTION CONTROL MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. PORTER’S
FIVE FORCES MODEL
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTE PRODUCTS
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. COMPETITIVE
RIVALRY
2.3. IMPACT
OF COVID-19 ON SURGICAL SITE INFECTION CONTROL MARKET
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
INSIGHTS
2.7. MARKET
DRIVERS
2.7.1. ENACTMENT
OF THE BEST INFECTION PREVENTION AND CONTROL PRACTICES
2.7.2. GROWING
AGING POPULATION
2.8. MARKET
RESTRAINTS
2.8.1. LACK
OF INFECTION CONTROL PROGRAMS
2.8.2. SURGING
USE OF OUTPATIENT PROCEDURES
2.8.3. INCREASED
USAGES OF MEDICAL DISPOSABLE ITEMS
2.9. MARKET
OPPORTUNITIES
2.9.1. RISING
INCIDENCE OF SURGICAL PROCEDURES
2.9.2. SIGNIFICANT
RISE IN THE OCCURRENCE OF COMPLICATIONS FROM HEALTHCARE-ASSOCIATED INFECTIONS
3. SURGICAL
SITE INFECTION CONTROL MARKET OUTLOOK – BY PROCEDURE
3.1. LAPAROSCOPY
3.2. ORTHOPEDIC
SURGERY
3.3. CARDIOVASCULAR
3.4. OBSTETRICS
AND GYNECOLOGY
3.5. WOUND
CLOSURE
3.6. PLASTIC
& RECONSTRUCTIVE SURGERY
3.7. THORACIC
SURGERY
3.8. MICROVASCULAR
3.9. UROLOGY
3.10. NEUROSURGERY
3.11. OTHER
PROCEDURES
4. SURGICAL
SITE INFECTION CONTROL MARKET OUTLOOK – BY TYPE OF INFECTION
4.1. SUPERFICIAL
INCISIONAL SSI
4.2. DEEP
INCISIONAL SSI
4.3. ORGAN
OR SPACE SSI
5. SURGICAL
SITE INFECTION CONTROL MARKET OUTLOOK – BY INDUSTRY VERTICAL
5.1. HOSPITALS
5.2. AMBULATORY
SURGICAL CENTERS
6. SURGICAL
SITE INFECTION CONTROL MARKET OUTLOOK – BY PRODUCT
6.1. DISINFECTANTS
6.2. MANUAL
REPROCESSORS SOLUTION
6.3. SURGICAL
DRAPES
6.4. SURGICAL
GLOVES
6.5. SKIN
PREPARATION SOLUTION
6.6. SURGICAL
IRRIGATION
6.7. SURGICAL
SCRUBS
6.8. HAIR
CLIPPERS
6.9. MEDICAL
NONWOVENS
6.10. OTHER
PRODUCTS
7. SURGICAL
SITE INFECTION CONTROL MARKET - MIDDLE EAST AND AFRICA
7.1. COUNTRY
ANALYSIS
7.1.1. ISRAEL
7.1.2. SAUDI
ARABIA
7.1.3. UNITED
ARAB EMIRATES
7.1.4. TURKEY
7.1.5. SOUTH
AFRICA
7.1.6. REST
OF MIDDLE EAST & AFRICA
8. COMPANY
PROFILES
8.1. SOTERA
HEALTH LLC
8.2. PACON
MANUFACTURING CORPORATION
8.3. STERIS
CORPORATION
8.4. AMERICAN
POLYFILM
8.5. BIOMERIEUX
SA
8.6. STRYKER
CORPORATION
8.7. BELIMED
AG
8.8. GAMA
HEALTHCARE
8.9. BECTON
DICKINSON AND COMPANY (BD)
8.10. 3M
COMPANY
8.11. GETINGE
AB
8.12. JOHNSON
& JOHNSON
8.13. ANSELL
LTD
8.14. KIMBERLY-CLARK
8.15. LAC-MAC
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.1.1. OBJECTIVES
OF STUDY
9.1.2. SCOPE
OF STUDY
9.2. SOURCES
OF DATA
9.2.1. PRIMARY
DATA SOURCES
9.2.2. SECONDARY
DATA SOURCES
9.3. RESEARCH
METHODOLOGY
9.3.1. EVALUATION
OF PROPOSED MARKET
9.3.2. IDENTIFICATION
OF DATA SOURCES
9.3.3. ASSESSMENT
OF MARKET DETERMINANTS
9.3.4. DATA
COLLECTION
9.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1 MIDDLE EAST AND AFRICA
SURGICAL SITE INFECTION CONTROL MARKET 2021-2028 (IN $ MILLION)
TABLE 2 VENDOR SCORECARD
TABLE 3 MIDDLE EAST AND AFRICA
SURGICAL SITE INFECTION CONTROL MARKET, BY PROCEDURE, 2021-2028 (IN $ MILLION)
TABLE 4 MIDDLE EAST AND AFRICA
SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, 2021-2028 (IN $
MILLION)
TABLE 5 MIDDLE EAST AND AFRICA
SURGICAL SITE INFECTION CONTROL MARKET, BY INDUSTRY VERTICAL, 2021-2028 (IN $
MILLION)
TABLE 6 MIDDLE EAST AND AFRICA
SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 7 MIDDLE EAST AND AFRICA
SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE 1 MIDDLE EAST AND AFRICA SURGICAL SITE
INFECTION CONTROL MARKET 2021-2028 (IN $ MILLION)
FIGURE 2 TYPES OF HEALTHCARE-ASSOCIATED INFECTIONS
FIGURE 3 MIDDLE EAST AND AFRICA SURGICAL SITE
INFECTION CONTROL MARKET, BY LAPAROSCOPY, 2021-2028 (IN $ MILLION)
FIGURE 4 MIDDLE EAST AND AFRICA SURGICAL SITE
INFECTION CONTROL MARKET, BY ORTHOPEDIC SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 5 MIDDLE EAST AND AFRICA SURGICAL SITE
INFECTION CONTROL MARKET, BY CARDIOVASCULAR, 2021-2028 (IN $ MILLION)
FIGURE 6 MIDDLE EAST AND AFRICA SURGICAL SITE
INFECTION CONTROL MARKET, BY OBSTETRICS AND GYNECOLOGY, 2021-2028 (IN $
MILLION)
FIGURE 7 MIDDLE EAST AND AFRICA SURGICAL SITE
INFECTION CONTROL MARKET, BY WOUND CLOSURE, 2021-2028 (IN $ MILLION)
FIGURE 8 MIDDLE EAST AND AFRICA SURGICAL SITE
INFECTION CONTROL MARKET, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2021-2028
(IN $ MILLION)
FIGURE 9 MIDDLE EAST AND AFRICA SURGICAL SITE
INFECTION CONTROL MARKET, BY THORACIC SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 10 MIDDLE EAST AND AFRICA SURGICAL SITE
INFECTION CONTROL MARKET, BY MICROVASCULAR, 2021-2028 (IN $ MILLION)
FIGURE 11 MIDDLE EAST AND AFRICA SURGICAL SITE INFECTION
CONTROL MARKET, BY UROLOGY, 2021-2028 (IN $ MILLION)
FIGURE 12 MIDDLE EAST AND AFRICA SURGICAL SITE
INFECTION CONTROL MARKET, BY NEUROSURGERY, 2021-2028 (IN $ MILLION)
FIGURE 13 MIDDLE EAST AND AFRICA SURGICAL SITE
INFECTION CONTROL MARKET, BY OTHER PROCEDURES, 2021-2028 (IN $ MILLION)
FIGURE 14 MIDDLE EAST AND AFRICA SURGICAL SITE
INFECTION CONTROL MARKET, BY SUPERFICIAL INCISIONAL SSI, 2021-2028 (IN $
MILLION)
FIGURE 15 MIDDLE EAST AND AFRICA SURGICAL SITE
INFECTION CONTROL MARKET, BY DEEP INCISIONAL SSI, 2021-2028 (IN $ MILLION)
FIGURE 16 MIDDLE EAST AND AFRICA SURGICAL SITE
INFECTION CONTROL MARKET, BY ORGAN OR SPACE SSI, 2021-2028 (IN $ MILLION)
FIGURE 17 MIDDLE EAST AND AFRICA SURGICAL SITE
INFECTION CONTROL MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)
FIGURE 18 MIDDLE EAST AND AFRICA SURGICAL SITE
INFECTION CONTROL MARKET, BY AMBULATORY SURGICAL CENTERS, 2021-2028 (IN $
MILLION)
FIGURE 19 MIDDLE EAST AND AFRICA SURGICAL SITE
INFECTION CONTROL MARKET, BY DISINFECTANTS, 2021-2028 (IN $ MILLION)
FIGURE 20 MIDDLE EAST AND AFRICA SURGICAL SITE
INFECTION CONTROL MARKET, BY MANUAL REPROCESSORS SOLUTION, 2021-2028 (IN $
MILLION)
FIGURE 21 MIDDLE EAST AND AFRICA SURGICAL SITE
INFECTION CONTROL MARKET, BY SURGICAL DRAPES, 2021-2028 (IN $ MILLION)
FIGURE 22 MIDDLE EAST AND AFRICA SURGICAL SITE
INFECTION CONTROL MARKET, BY SURGICAL GLOVES, 2021-2028 (IN $ MILLION)
FIGURE 23 MIDDLE EAST AND AFRICA SURGICAL SITE
INFECTION CONTROL MARKET, BY SKIN PREPARATION SOLUTION, 2021-2028 (IN $
MILLION)
FIGURE 24 MIDDLE EAST AND AFRICA SURGICAL SITE
INFECTION CONTROL MARKET, BY SURGICAL IRRIGATION, 2021-2028 (IN $ MILLION)
FIGURE 25 MIDDLE EAST AND AFRICA SURGICAL SITE
INFECTION CONTROL MARKET, BY SURGICAL SCRUBS, 2021-2028 (IN $ MILLION)
FIGURE 26 MIDDLE EAST AND AFRICA SURGICAL SITE
INFECTION CONTROL MARKET, BY HAIR CLIPPERS, 2021-2028 (IN $ MILLION)
FIGURE 27 MIDDLE EAST AND AFRICA SURGICAL SITE
INFECTION CONTROL MARKET, BY MEDICAL NONWOVENS, 2021-2028 (IN $ MILLION)
FIGURE 28 MIDDLE EAST AND AFRICA SURGICAL SITE INFECTION
CONTROL MARKET, BY OTHER PRODUCTS, 2021-2028 (IN $ MILLION)
FIGURE 29 ISRAEL SURGICAL SITE INFECTION CONTROL MARKET
2021-2028 (IN $ MILLION)
FIGURE 30 SAUDI ARABIA SURGICAL SITE INFECTION CONTROL
MARKET 2021-2028 (IN $ MILLION)
FIGURE 31 UNITED ARAB EMIRATES SURGICAL SITE INFECTION
CONTROL MARKET 2021-2028 (IN $ MILLION)
FIGURE 32 TURKEY SURGICAL SITE INFECTION CONTROL MARKET
2021-2028 (IN $ MILLION)
FIGURE 33 SOUTH AFRICA SURGICAL SITE INFECTION CONTROL
MARKET 2021-2028 (IN $ MILLION)
FIGURE 34 REST OF MIDDLE EAST & AFRICA SURGICAL
SITE INFECTION CONTROL MARKET 2021-2028 (IN $ MILLION)